Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CryoLife, Inc. stock logo
CRY
CryoLife
$19.05
$16.95
$32.34
$703.22M1.53198,221 shs7,792 shs
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
$20.00
$19.98
$12.26
$20.57
$843.96M0.74765,906 shs4,300 shs
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
$5.64
+5.0%
$4.90
$1.04
$11.20
$279.46M2.83224,567 shs125,095 shs
SI-BONE, Inc. stock logo
SIBN
SI-BONE
$15.27
-1.9%
$16.97
$14.84
$29.51
$626.99M1.2437,720 shs312,421 shs
Surmodics, Inc. stock logo
SRDX
Surmodics
$26.92
+6.0%
$29.14
$16.79
$39.41
$383.34M1.0158,598 shs52,914 shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CryoLife, Inc. stock logo
CRY
CryoLife
0.00%0.00%0.00%0.00%0.00%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.00%0.00%0.00%0.00%+0.10%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
+4.68%-2.89%+4.47%+0.94%-47.25%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
+0.91%+1.90%+2.03%-18.28%-29.88%
Surmodics, Inc. stock logo
SRDX
Surmodics
-4.15%-3.90%-8.21%-26.85%+5.27%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CryoLife, Inc. stock logo
CRY
CryoLife
N/AN/AN/AN/AN/AN/AN/AN/A
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.2381 of 5 stars
0.00.00.04.20.01.70.6
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
0.7055 of 5 stars
1.04.00.00.01.93.30.6
SI-BONE, Inc. stock logo
SIBN
SI-BONE
4.2409 of 5 stars
4.52.00.03.31.42.50.6
Surmodics, Inc. stock logo
SRDX
Surmodics
4.0574 of 5 stars
3.52.00.03.41.61.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CryoLife, Inc. stock logo
CRY
CryoLife
N/AN/AN/AN/A
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
N/AN/AN/AN/A
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
2.00
Hold$4.60-18.44% Downside
SI-BONE, Inc. stock logo
SIBN
SI-BONE
3.00
Buy$26.6774.63% Upside
Surmodics, Inc. stock logo
SRDX
Surmodics
3.00
Buy$59.00119.17% Upside

Current Analyst Ratings

Latest SGHT, CRY, SIBN, CSII, and SRDX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold
4/10/2024
Surmodics, Inc. stock logo
SRDX
Surmodics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$47.00
4/3/2024
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$27.00
3/28/2024
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$25.00
2/27/2024
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$25.00 ➝ $26.00
2/27/2024
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$25.00
2/27/2024
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$26.00 ➝ $24.00
2/1/2024
Surmodics, Inc. stock logo
SRDX
Surmodics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$44.00 ➝ $47.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CryoLife, Inc. stock logo
CRY
CryoLife
$253.23M0.00N/A23.30$8.46 per share0.00
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
$239.84M3.52N/AN/A$6.12 per share3.27
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
$81.06M3.45N/AN/A$2.47 per share2.28
SI-BONE, Inc. stock logo
SIBN
SI-BONE
$138.89M4.51N/AN/A$4.18 per share3.65
Surmodics, Inc. stock logo
SRDX
Surmodics
$132.58M2.89$0.80 per share33.78$8.48 per share3.17

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CryoLife, Inc. stock logo
CRY
CryoLife
-$16.68M$0.03596.200.00N/A0.63%4.24%1.63%N/A
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
-$36.93M-$0.97N/AN/AN/A-15.79%-15.39%-11.93%N/A
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-$55.55M-$1.14N/AN/AN/A-68.53%-41.94%-30.64%5/2/2024 (Confirmed)
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$43.34M-$1.14N/AN/AN/A-31.20%-28.22%-20.53%5/6/2024 (Confirmed)
Surmodics, Inc. stock logo
SRDX
Surmodics
-$1.54M$0.3870.84N/AN/A3.99%8.06%5.11%5/1/2024 (Confirmed)

Latest SGHT, CRY, SIBN, CSII, and SRDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2024N/A
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$0.29N/A+$0.29N/AN/AN/A  
5/2/2024N/A
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-$0.29N/A+$0.29N/AN/AN/A  
5/1/2024N/A
Surmodics, Inc. stock logo
SRDX
Surmodics
-$0.36N/A+$0.36N/AN/AN/A  
3/7/2024Q4 2023
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-$0.35-$0.22+$0.13-$0.22$18.70 million$18.75 million    
2/26/2024Q4 2023
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$0.29-$0.27+$0.02-$0.27$38.60 million$38.86 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CryoLife, Inc. stock logo
CRY
CryoLife
N/AN/AN/AN/AN/A
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
N/AN/AN/AN/AN/A
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
N/AN/AN/AN/AN/A
SI-BONE, Inc. stock logo
SIBN
SI-BONE
N/AN/AN/AN/AN/A
Surmodics, Inc. stock logo
SRDX
Surmodics
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CryoLife, Inc. stock logo
CRY
CryoLife
0.99
4.21
2.93
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
0.08
6.04
4.92
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
0.26
13.29
12.65
SI-BONE, Inc. stock logo
SIBN
SI-BONE
0.21
9.01
8.15
Surmodics, Inc. stock logo
SRDX
Surmodics
0.24
4.84
3.97

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CryoLife, Inc. stock logo
CRY
CryoLife
81.57%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
86.61%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
55.51%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
98.11%
Surmodics, Inc. stock logo
SRDX
Surmodics
96.63%

Insider Ownership

CompanyInsider Ownership
CryoLife, Inc. stock logo
CRY
CryoLife
4.50%
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
3.80%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
27.10%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
5.40%
Surmodics, Inc. stock logo
SRDX
Surmodics
8.90%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CryoLife, Inc. stock logo
CRY
CryoLife
1,20039.33 million37.56 millionOptionable
Cardiovascular Systems, Inc. stock logo
CSII
Cardiovascular Systems
78042.20 million40.59 millionOptionable
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
21449.55 million36.12 millionOptionable
SI-BONE, Inc. stock logo
SIBN
SI-BONE
34441.06 million38.85 millionOptionable
Surmodics, Inc. stock logo
SRDX
Surmodics
37614.24 million12.97 millionOptionable

SGHT, CRY, SIBN, CSII, and SRDX Headlines

SourceHeadline
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
businesswire.com - April 19 at 7:00 AM
Will SurModics (SRDX) Report Negative Q2 Earnings? What You Should KnowWill SurModics (SRDX) Report Negative Q2 Earnings? What You Should Know
finance.yahoo.com - April 17 at 2:18 PM
Will SurModics (SRDX) Report Negative Q2 Earnings? What You Should KnowWill SurModics (SRDX) Report Negative Q2 Earnings? What You Should Know
zacks.com - April 17 at 11:06 AM
Surmodics (NASDAQ:SRDX) Upgraded by StockNews.com to "Strong-Buy"Surmodics (NASDAQ:SRDX) Upgraded by StockNews.com to "Strong-Buy"
americanbankingnews.com - April 17 at 3:42 AM
Surmodics (NASDAQ:SRDX) Rating Increased to Strong-Buy at StockNews.comSurmodics (NASDAQ:SRDX) Rating Increased to Strong-Buy at StockNews.com
marketbeat.com - April 16 at 11:04 PM
Investors in Surmodics (NASDAQ:SRDX) have unfortunately lost 54% over the last three yearsInvestors in Surmodics (NASDAQ:SRDX) have unfortunately lost 54% over the last three years
finance.yahoo.com - April 13 at 8:40 AM
Q1 2025 Earnings Estimate for Surmodics, Inc. Issued By Zacks Research (NASDAQ:SRDX)Q1 2025 Earnings Estimate for Surmodics, Inc. Issued By Zacks Research (NASDAQ:SRDX)
marketbeat.com - April 11 at 7:42 AM
Analysts Offer Insights on Healthcare Companies: Genprex (GNPX) and SurModics (SRDX)Analysts Offer Insights on Healthcare Companies: Genprex (GNPX) and SurModics (SRDX)
markets.businessinsider.com - April 10 at 4:59 PM
Surmodics (SRDX) "Buy" Rating Reiterated at Needham & Company LLCSurmodics' (SRDX) "Buy" Rating Reiterated at Needham & Company LLC
marketbeat.com - April 10 at 11:26 AM
Q4 2025 EPS Estimates for Surmodics, Inc. Boosted by Zacks Research (NASDAQ:SRDX)Q4 2025 EPS Estimates for Surmodics, Inc. Boosted by Zacks Research (NASDAQ:SRDX)
marketbeat.com - April 10 at 8:44 AM
New Strong Buy Stocks for April 9thNew Strong Buy Stocks for April 9th
zacks.com - April 9 at 7:16 AM
Should You Think About Buying Surmodics, Inc. (NASDAQ:SRDX) Now?Should You Think About Buying Surmodics, Inc. (NASDAQ:SRDX) Now?
finance.yahoo.com - March 23 at 1:09 PM
Heres Why You Should Hold Surmodics (SRDX) Stock for NowHere's Why You Should Hold Surmodics (SRDX) Stock for Now
zacks.com - March 20 at 12:30 PM
Are Surmodics, Inc.s (NASDAQ:SRDX) Mixed Financials Driving The Negative Sentiment?Are Surmodics, Inc.'s (NASDAQ:SRDX) Mixed Financials Driving The Negative Sentiment?
finance.yahoo.com - March 2 at 1:31 PM
Surmodics to Participate in Upcoming Investor Conferences in March and AprilSurmodics to Participate in Upcoming Investor Conferences in March and April
businesswire.com - February 27 at 8:00 AM
SYK Jun 2024 290.000 putSYK Jun 2024 290.000 put
ca.finance.yahoo.com - February 6 at 1:03 PM
Heres What Analysts Are Forecasting For Surmodics, Inc. (NASDAQ:SRDX) After Its First-Quarter ResultsHere's What Analysts Are Forecasting For Surmodics, Inc. (NASDAQ:SRDX) After Its First-Quarter Results
finance.yahoo.com - February 4 at 9:23 AM
Heres Why Shareholders May Want To Be Cautious With Increasing Surmodics, Inc.s (NASDAQ:SRDX) CEO Pay PacketHere's Why Shareholders May Want To Be Cautious With Increasing Surmodics, Inc.'s (NASDAQ:SRDX) CEO Pay Packet
finance.yahoo.com - February 2 at 5:33 PM
Surmodics, Inc. (NASDAQ:SRDX) Q1 2024 Earnings Call TranscriptSurmodics, Inc. (NASDAQ:SRDX) Q1 2024 Earnings Call Transcript
finance.yahoo.com - February 2 at 12:26 PM
Surmodics (SRDX) Q1 Earnings Top Estimates, Revises FY24 ViewSurmodics (SRDX) Q1 Earnings Top Estimates, Revises FY24 View
finance.yahoo.com - February 2 at 12:26 PM
Surmodics Shares Decline 10% on Investors Lofty Expectations for SurVeilSurmodics Shares Decline 10% on Investors' Lofty Expectations for SurVeil
marketwatch.com - February 1 at 5:53 PM
Surmodics Inc (SRDX) Posts Revenue Growth and Narrows Net Loss in Q1 Fiscal 2024Surmodics Inc (SRDX) Posts Revenue Growth and Narrows Net Loss in Q1 Fiscal 2024
finance.yahoo.com - February 1 at 5:53 PM
Surmodics beats top-line and bottom-line estimates; updates FY24 outlookSurmodics beats top-line and bottom-line estimates; updates FY24 outlook
msn.com - February 1 at 12:52 PM
SurModics (SRDX) Reports Break-Even Earnings for Q1SurModics (SRDX) Reports Break-Even Earnings for Q1
finance.yahoo.com - February 1 at 12:52 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

CryoLife logo

CryoLife

NYSE:CRY
CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.
Cardiovascular Systems logo

Cardiovascular Systems

NASDAQ:CSII
Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.
Sight Sciences logo

Sight Sciences

NASDAQ:SGHT
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.
SI-BONE logo

SI-BONE

NASDAQ:SIBN
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Surmodics logo

Surmodics

NASDAQ:SRDX
Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.